Home Logon FTA Investment Managers Blog Subscribe About Us Contact Us

Search by Ticker, Keyword or CUSIP       
 
 
 
Blog Home
 

  Factoid - July 15, 2026
Posted Under: Factoid • Sectors • Health Care-Pharmaceutical-Biotech

The U.S. Food and Drug Administration (FDA) reported that it approved 23 new drugs in the first half of 2026, up from 16 over the same period in 2025. For comparison, the FDA approved 20 new drugs in the first half of 2018 before reaching a record 59 approvals by the end of the year.

Posted on Wednesday, July 15, 2026 @ 8:44 AM • Post Link Print this post Printer Friendly

These posts were prepared by First Trust Advisors L.P., and reflect the current opinion of the authors. They are based upon sources and data believed to be accurate and reliable. Opinions and forward looking statements expressed are subject to change without notice. This information does not constitute a solicitation or an offer to buy or sell any security.
Search Posts


 PREVIOUS POSTS
ETF Data Watch: Asset Flows Monitor July 2026 Edition
The Road Back to Nuclear Power: Opportunities and Pitfalls Ahead
Market Minute – July 2026
Josef Schuster - What Does History Say About Post-IPO Performance Trends?
ETF Data Watch: Asset Flows Monitor June 2026 Edition
Mandeep Singh – Is the SaaS-Pocalypse Over, and Where Are We in the AI Capex Cycle?
Market Minute – June 2026
Brian Wesbury - Can AI Make a Pencil?
Brian Murphy – What Does AI Disruption Mean for Private Credit?
Asset Flows Monitor May 2026 Edition
Archive
Skip Navigation Links.
Search by Topic
Skip Navigation Links.

 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
Follow First Trust:  
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  First Trust Funds Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2026 All rights reserved.